Artificial Intelligence (AI) in Drug Discovery Market Report 2022-2032

Visiongain
VISION10191
$5,056.00

The Artificial Intelligence (AI) in Drug Discovery Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.


The Rising Adoption of Cloud-Based Applications & Services Is Driving the Market

Artificial intelligence (AI) is defined as a machine that employs modern technology to do tasks that are similar to those performed by the human mind. The primary purpose of drug discovery research is to find medications that can aid in the prevention or treatment of specific diseases. The difficulties of reviewing, obtaining, and utilising data to solve difficult medical problems fueled demand for artificial intelligence (AI) in the drug discovery business. The market for artificial intelligence in drug development is divided into offering, technology, type, applications, and region. The growing number of cross-industry collaborations and partnerships, the increasing need to control drug discovery & development costs and reduce overall time taken in this process, the rising adoption of cloud-based applications & services, and the impending patent expiration of blockbuster drugs are all driving the artificial intelligence in drug discovery market. On the other side, the market's expansion is being hampered by a paucity of data sets in the field of drug discovery and an insufficient supply of competent workers.


The Lack of Data Is a Recurring Problem Throughout All Industries Implementing AI

The shortage of data is a reoccurring issue in all industries that are deploying AI. A standard biological investigation requires a minimum of five samples to be legitimate. Meanwhile, in order to function well, most machine learning algorithms must be trained on hundreds of thousands of data points or samples. This is why obtaining high-quality healthcare data is critical something that has proven increasingly challenging over time. The challenge is due to the disorganised and fragmented health data scattered across many data platforms and organisations. Patients' insurance and healthcare providers change too frequently, making data collection difficult.


What Are These Questions You Should Ask Before Buying A Market Research Report?

• How is the artificial intelligence (AI) in drug discovery market evolving?

• What is driving and restraining the artificial intelligence (AI) in drug discovery market?

• How will each artificial intelligence (AI) in drug discovery submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?

• How will the market shares for each artificial intelligence (AI) in drug discovery submarket develop from 2022 to 2032?

• What will be the main driver for the overall market from 2022 to 2032?

• Will leading artificial intelligence (AI) in drug discovery markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?

• Who are the leading players and what are their prospects over the forecast period?

• What are the artificial intelligence (AI) in drug discovery projects for these leading companies?

• How will the industry evolve during the period between 2020 and 2032?What are the implication of artificial intelligence (AI) in drug discovery projects taking place now and over the next 10 years?

• Is there a greater need for product commercialisation to further scale the artificial intelligence (AI) in drug discovery market?

• Where is the artificial intelligence (AI) in drug discovery market heading? And how can you ensure you are at the forefront of the market?

• What can be the best investment options for new product and service lines?

• What are the key prospects for moving companies into a new growth path? C-suite?


You need to discover how this will impact the artificial intelligence (AI) in drug discovery market today, and over the next 10 years:

• Our 461-page report provides 270 tables and 264 charts/graphs exclusively to you.

• The report highlights key lucrative areas in the industry so you can target them – NOW.

• Contains in-depth analyse of global, regional and national sales and growth

• Highlights for you the key successful trends, changes and revenue projections made by your competitors


This report tells you TODAY how the artificial intelligence (AI) in drug discovery market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.


Forecasts to 2032 and other analyses reveal the commercial prospects

• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.

• You find original analyses, with business outlooks and developments.

• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising artificial intelligence (AI) in drug discovery prices and recent developments.


This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.


Segments Covered in this report


Market Segment by Offering

• AI Software

• AI Services


Market Segment by Technology

• Deep Learning

• Supervised Learning

• Reinforcement Learning

• Unsupervised Learning

• Other Technology


Market Segment by Applications

• Oncology

• Infectious Diseases

• Neurological Disorders

• Metabolic Diseases

• Cardiovascular Diseases

• Other Applications


Market Segment by Type

• Target Identification

• Molecule Screening

• Drug Design and Drug Optimization

• Preclinical and Clinical Testing


In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 20 leading national markets:


North America

• U.S.

• Canada

• Mexico


Europe

• Germany

• Spain

• United Kingdom

• France

• Italy

• Rest of Europe


Asia Pacific

• China

• Japan

• India

• Australia

• South Korea

• Rest of Asia Pacific


LAMEA

• Brazil

• Turkey

• Saudi Arabia

• South Africa

• UAE

• Rest of Latin America, Middle East and Africa


The report also includes profiles and for some of the leading companies in the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032, with a focus on this segment of these companies’ operations.


Leading companies and the potential for market growth

• Atomwise

• Benevolent AI

• Berg Health

• Bioage

• Biosymetrics

• Cloud Pharmaceuticals

• Cyclica

• Deep Genomics

• DeepMind

• Envisagenics

• Euretos

• Exscientia

• GNS Healthcare

• IBM Corporation

• Insilico Medicine


Overall world revenue for Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 in terms of value the market will surpass US$919 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.


How the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 Market report helps you?

In summary, our 461-page report provides you with the following knowledge:


• Revenue forecasts to 2032 for Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 Market, with forecasts for application, technology, type, offering, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues


• Revenue forecasts to 2032 for 4 regional and 20 key national markets – See forecasts for the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.


• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the major companies involved in the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 Market.


Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.


Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.

'

1 Report Overview
1.1 Introduction to Artificial Intelligence (AI) in Drug Discovery Market
1.2 Global Artificial Intelligence (AI) in Drug Discovery Market Overview
1.3 What Are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Artificial Intelligence (AI) in Drug Discovery Market Definition
1.6 Why You Should Read this Report
1.7 What this Report Delivers
1.8 Key Questions Answered by this Analytical Report Include:
1.9 Who is this Report for?
1.10 Research Methodology
1.10.1 Primary Research
1.10.2 Secondary Research
1.10.3 Market Evaluation & Forecasting Methodology
1.11 Frequently Asked Questions (FAQs)
1.12 Associated Reports
1.13 About

2 Executive Summary

3 Artificial Intelligence (AI) in Drug Discovery Industry Structure
3.1 Overview
3.2 Industry Value Chain Analysis
3.3 Artificial Intelligence Is Changing Drug Discovery
3.4 Networks and Tools for AI
3.5 AI in the Pharmaceutical Product Lifecycle
3.6 AI in Drug Discovery
3.6.1 AI in Drug Design
3.6.2 AI in Polypharmocology
3.6.3 AI in Chemical Sythesis
3.6.4 AI in drug repurposing
3.6.5 AI in drug screening
3.7 AI in Drug Screening
3.8 AI in Designing Drug Molecules
3.9 AI in Advancing Pharmaceutical Product Development
3.10 AI in Pharmaceutical Manufacturing

4 Global Market Dynamics
4.1 Market Driving Factors
4.1.1 AI Utilizes the Latest Advances in Biology and Computing to Develop State-of-the-Art Algorithms for Drug Discovery
4.1.2 Thanks to AI, the Cost and Timelines of Developing a New Treatment Will Be Rewritten
4.1.3 Artificial Intelligence (AI) Has Been a Game-Changer for the Pharmaceutical Sector Throughout the Value Chain
4.2 Market Restraining Factors
4.2.1 AI Predictions Are as Good as the Algorithms Used to Investigate a Dataset
4.2.2 AI Can Suffer from Algorithm Bias
4.2.3 Setting Up AI-Based Machines, Computers Entails Huge Costs
4.3 Opportunities in the Global Market
4.3.1 A New Wave of Drug Discovery is Setting the Ideal for the World
4.3.2 AI Has Received a Lot of Attention in the Pharmaceutical Business for Medication Discovery and Development
4.3.3 Understanding the Molecular Causes of a Disease in a Precisely Stratified Patient Sample Is Critical for Drug Discovery Programmes to Hit the Mark and Prevent Late-Stage Effectiveness Failures
4.4 Challenges in the Global Market
4.4.1 The Lack of Data Is a Recurring Problem Throughout All Industries Implementing AI
4.4.2 AI Systems Are Prone to Errors, Which Eventually Leads to a Significant Problems
4.4.3 Another Hindrance in Using AI to Predict Drug Targets Remains to Translate Traditional Basic Research Conducted in Labs Worldwide into a Language That a Computer Can Understand
4.5 Swot Analysis for Global Market
4.5.1 Market Strengths
4.5.2 Market Weakness
4.5.3 Market Opportunites
4.5.4 Market Threats
4.6 PEST Analysis for Global Market
4.6.1 Political Factors
4.6.2 Economic Factors
4.6.3 Social Factors
4.6.4 Technology Factors
4.7 Porter’s Five Forces
4.7.1 Threats of New Entrants- High
4.7.2 Bargaining Power of Suppliers- High
4.7.3 Bargaining Power of Buyers- Low
4.7.4 Threats of Substitute - Low
4.7.5 Rivalry among the Existing Competitors - High

5 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis
5.1 Global Market Outlook
5.1.1 Global Artificial Intelligence (AI) in Drug Discovery Market is Expected to Grow at Rapid Pace Due to Huge Drugs Demand
5.1.2 The Adoption of AI Solutions in the Clinical Trial Process Eliminates Various Obstacles

6 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032
6.1 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Region
6.2 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
6.3 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
6.4 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
6.5 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Type

7 North America Artificial Intelligence (AI) in Drug Discovery Market Analysis
7.1 North America Market Outlook
7.1.1 North America Is the Largest Growing Regional Market for AI in Drug Discovery
7.1.2 Postera, a North American Biotechnology Company Specializing in Machine Learning for Preclinical Drug Discovery is Chosen for Further Innovation
7.2 US Artificial Intelligence in Drug Discovery Market Analysis
7.2.1 AI Spending and Funding in US is Getting the Light it Needs
7.2.2 The U.S. Has a Clear Advantage in the Race to Become an AI Superpower
7.3 Canada Artificial Intelligence in Drug Discovery Market Analysis
7.3.1 Canada Offers Resources to Local and Foreign AI-Focused Talent and Organizations
7.3.2 Companies Collaborations and Partnerships in Canada is Accelerating the Usecase of AI in Drug Development
7.4 Mexico Artificial Intelligence (AI) in Drug Discovery Market Analysis
7.4.1 Mexico is One of the First Ten Countries in the World to Adopt an Artificial Intelligence Policy, and it Leads Latin America
7.4.2 Role of Government in Helping to Shape the Development and Uses of AI in Mexico
7.5 North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Country
7.6 North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
7.7 North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
7.8 North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications

8 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis
8.1 Europe Market Outlook
8.1.1 The EU’s Approach to Artificial Intelligence Centres on Excellence and Trust, Aiming to Boost Research and Industrial Capacity and Ensure Fundamental Rights
8.1.2 European Proposal for a Legal Framework on AI
8.2 Germany Artificial Intelligence (AI) in Drug Discovery Market Analysis
8.2.1 In Germany, an Algorithm Based on the Brain's Self-Organizing Capacity Has been Developed to Tackle Escalating Medication Development Costs
8.2.2 Germany is at the Forefront of Artificial Intelligence (AI) in Europe
8.3 UK Artificial Intelligence in Drug Discovery Market Analysis
8.3.1 There is Huge Increase in Demand for Ai Professionals in UK
8.3.2 AI could be a significant driver of productivity and GDP growth for the UK economy
8.4 France Artificial Intelligence in Drug Discovery Market Analysis
8.4.1 French Government Supports AI in Healthcare
8.4.2 French Companies Are Coming Together to Find Innovatiove Solutions for Drug Development
8.5 Italy Artificial Intelligence in Drug Discovery Market Analysis
8.5.1 Some Italian Companies Are Now Slowly Beginning to Pilot New Technologies Particularly in AI
8.5.2 Impact of AI on Italy’s Economy and Growth
8.6 Spain Artificial Intelligence in Drug Discovery Market Analysis
8.6.1 Impact of AI in Spain
8.6.2 IndesIA is a Spanish Association of Artificial Intelligence for Industry
8.7 Rest of Europe Artificial Intelligence in Drug Discovery Market Analysis
8.7.1 Ireland Has the Highest Share of Businesses Using AI Applications in Europe
8.7.2 European Commission Is Hoping to Set New Oversight Standards in a Bid to Create ‘Trustworthy AI’
8.8 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Country
8.9 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
8.10 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
8.11 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
8.12 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Type

9 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis
9.1 Asia-Pacific Market Outlook
9.1.1 The Growing Startup Culture in Asian Countries Has Also Influenced the Growth of AI, Sspecially in Countries like China and India
9.1.2 Southeast Asia is Still in the Early Stages of AI Adoption
9.2 China Artificial Intelligence in Drug Discovery Market Analysis
9.2.1 Chinese Firms Are Relying on AI to Put More Drugs on the Market, and by Extrapolation Extend Better Services
9.2.2 Chinese Firm Marks the World’s First Phase-1 Clinical Trial of a Drug Developed with AI Technology from Scratch
9.3 India Artificial Intelligence in Drug Discovery Market Analysis
9.3.1 Intuition System, a Company from India is Heating up the Game in AI
9.3.2 Other Startups and Companies in India is on the Innovatiove Track Regarding AI in Drug Discovery
9.4 Japan Artificial Intelligence in Drug Discovery Market Analysis
9.4.1 A Powerful New Use for AI in Drug Discovery Has Been Discovered by a Japanese Company
9.4.2 The Pharmaceuticals and Medical Devices Agency (PDMA) Approved 123 New Drug Products in Japan
9.5 South Korea Artificial Intelligence in Drug Discovery Market Analysis
9.5.1 This South Korean Firm Is on the Cutting Edge of AI-Driven Drug Development
9.5.2 South Korea to Use AI in Drug Discovery as the Government Gives Approval
9.6 Australia Artificial Intelligence in Drug Discovery Market Analysis.
9.6.1 Experts from Two Australian University Groups Working on AI in Drug Development Are Supervising the Phd Research
9.6.2 Contribution of Australia in AI in Drug Discovery Research
9.7 Rest of Asia-Pacific Artificial Intelligence in Drug Discovery Market Analysis.
9.7.1 Southeast Asian Countries are also Committing to the Development and Research Involving AI
9.7.2 Singapore’s Leading Firm is Taking a Big Leap in AI
9.8 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Country
9.9 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
9.10 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
9.11 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
9.12 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Type

10 LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis
10.1 LAMEA Market Outlook
10.1.1 Latin America’s Growing Artificial Intelligence Wave Can Give Boost to the Low Productivity Countries
10.1.2 AI is Poised to Impact Africa in Several Ways in Drug Discovery
10.2 Brazil Artificial Intelligence in Drug Discovery Market Analysis.
10.2.1 The Brazilian House of Representatives Has Passed a Law that Establishes Legal Guidelines for Artificial Intelligence
10.2.2 Brazil Excels in the Use of Artificial Intelligence
10.3 Turkey Artificial Intelligence in Drug Discovery Market Analysis.
10.3.1 Turkey Plans to Become Among the Top 20 Countries in the International AI Indices
10.3.2 Artificial intelligence (AI) is the New “Oil” of the Near Future and can Provide Huge Opportunities for Turkey
10.4 Saudi Arabia Artificial Intelligence in Drug Discovery Market Analysis.
10.4.1 Saudi Arabia Uses AI in Drug Discovery
10.4.2 Saudi Arabia is Uniquely Placed to Drive Artificial Intelligence Innovation Post-Coronavirus Pandemic
10.5 South Africa Artificial Intelligence in Drug Discovery Market Analysis.
10.5.1 Innovations in South Africa in AI
10.5.2 South Africa to Participate in AI Driven Future in Health and Drug Development Sector
10.6 UAE Artificial Intelligence in Drug Discovery Market Analysis.
10.6.1 The UAE Government launched ‘UAE Strategy for Artificial Intelligence (AI)’
10.6.2 Drug Discovery from Artificial Intelligence Partnership Announced In UAE
10.7 Rest of LAMEA Artificial Intelligence in Drug Discovery Market Analysis.
10.7.1 AI’s applications in Latin America are already becoming reality in Drug Discovery
10.7.2 AI landscape in sub-Saharan Africa is Improving
10.8 LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis by Country
10.9 LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
10.10 LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
10.11 LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
10.12 LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis

11 Leading Company Analysis and Profile
11.1 Atomwise
11.1.1 Company Snapshot
11.1.2 Company Overview
11.1.3 Company Product Benchmarking
11.1.4 Company Recent Developments
11.2 Benevolent AI
11.2.1 Company Snapshot
11.2.2 Company Overview
11.2.3 Company Product Benchmarking
11.2.4 Company Recent Developments
11.3 Berg Health
11.3.1 Company Snapshot
11.3.2 Company Overview
11.3.3 Company Product Benchmarking
11.3.4 Company Recent Developments
11.4 Bioage
11.4.1 Company Snapshot
11.4.2 Company Overview
11.4.3 Company Product Benchmarking
11.4.4 Company Recent Developments
11.5 Biosymetrics
11.5.1 Company Snapshot
11.5.2 Company Overview
11.5.3 Company Product Benchmarking
11.5.4 Company Recent Developments
11.6 Cloud Pharmaceuticals
11.6.1 Company Snapshot
11.6.2 Company Overview
11.6.3 Company Product Benchmarking
11.7 Cyclica
11.7.1 Company Snapshot
11.7.2 Company Overview
11.7.3 Company Product Benchmarking
11.7.4 Company Recent Developments
11.8 Deep Genomics
11.8.1 Company Snapshot
11.8.2 Company Overview
11.8.3 Company Product Benchmarking
11.8.4 Company Recent Developments
11.9 DeepMind
11.9.1 Company Snapshot
11.9.2 Company Overview
11.9.3 Company Product Benchmarking
11.9.4 Company Recent Developments
11.10 Envisagenics
11.10.1 Company Snapshot
11.10.2 Company Overview
11.10.3 Company Product Benchmarking
11.10.4 Company Recent Developments
11.11 Euretos
11.11.1 Company Snapshot
11.11.2 Company Overview
11.11.3 Company Product Benchmarking
11.11.4 Company Recent Developments
11.12 Exscientia
11.12.1 Company Snapshot
11.12.2 Company Overview
11.12.3 Company Recent Developments
11.13 GNS Healthcare
11.13.1 Company Snapshot
11.13.2 Company Overview
11.13.3 Company Product Benchmarking
11.13.4 Company Recent Developments
11.14 IBM Corporation
11.14.1 Company Snapshot
11.14.2 Company Overview
11.14.3 Company Financial Profile
11.14.4 Company Product Benchmarking
11.14.5 Company Recent Developments
11.15 Insilico Medicine
11.15.1 Company Snapshot
11.15.2 Company Overview
11.15.3 Company Product Benchmarking
11.15.4 Company Recent Developments

12 Conclusion and Recommendations
12.1 Conclusion Summary
12.2 Recommendations

13 Glossary Terms
13.1 Associated Reports

List of Tables
Table 1 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 2 Global Artificial Intelligence (AI) in Drug Discovery Market Snapshot, 2022 & 2032 (US$million, CAGR %)
Table 3 Artificial Intelligence (AI) in Drug Discovery Swot Analysis
Table 4 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 5 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 6 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 7 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 8 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 9 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 10 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 11 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 12 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 13 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 14 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 15 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 16 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 17 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 18 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 19 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 20 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 21 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 22 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 23 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 24 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 25 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 26 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 27 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 28 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 29 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 30 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 31 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 32 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 33 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 34 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 35 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 36 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 37 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 38 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 39 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 40 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 41 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 42 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 43 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 44 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 45 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 46 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 47 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 48 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 49 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 50 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 51 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 52 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 53 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 54 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 55 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 56 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 57 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 58 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 59 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 60 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 61 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 62 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 63 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 64 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 65 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 66 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 67 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 68 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 69 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 70 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 71 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 72 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 73 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 74 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 75 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 76 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 77 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 78 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 79 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 80 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 81 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 82 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 83 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 84 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 85 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 86 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 87 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 88 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 89 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 90 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 91 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 92 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 93 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 94 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 95 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 96 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 97 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 98 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 99 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 100 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 101 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 102 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 103 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 104 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 105 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 106 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 107 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 108 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 109 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 110 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 111 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 112 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 113 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 114 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 115 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 116 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 117 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 118 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 119 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 120 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 121 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 122 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 123 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 124 Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 125 Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 126 Europe Art

List of Companies Profiled in the report
Atomwise
Benevolent AI
Berg Health
Bioage
Biosymetrics
Cloud Pharmaceuticals
Cyclica
Deep Genomics
DeepMind
Envisagenics
Euretos
Exscientia
GNS Healthcare
IBM Corporation
Insilico Medicine

List of Other Companies Mentioned in the report
Accenture
AdventHealth
AstraZeneca
ATAI Lifesciences AG
Bayer
BioMarin Pharmaceuticals, Inc.
BioMotiv
Blue Oak Pharmaceuticals
Boehringer Ingelheim
Bridge Biotherapeutics
Bristol Myers Squibb
Celgene
Cereval Therapeutics
Charles River Laboratories
Datavant
Deutsche Telekom
Diamond Light Source
DNDi
Eli Lilly and Company
Elsevier
Enamine, Ltd.
Eurofarma
Excelra
FMC Corporation
Gilead Sciences, Inc.
GitHub, Inc.
GlaxoSmithKline
Google, Inc.
GT Apeiron Therapeutics
Gustave Roussy
Hansoh Pharmaceutical Group Company Limited
Haystack Sciences
HollandBIO
Huadong Medicine
Instana
Janssen
Mannin Research
NeuroTheryX Canada, Ltd.
Novartis
Nuance Communications, Inc.
NYU Langone Health
Pfizer
Rallybio
Red Hat, Inc.
Roche
Sema4
ServiceNow
Sophia Genetics
SRI International
Sumitomo Dainippon Pharma
Temasek
UnitedHealth Group
Wave Life Sciences, Ltd.
WuXi AppTec
Zeiss Group

List of Associations Mentioned in the Report
Alliance for Clinical Trials in Oncology
Bill & Melinda Gates Foundation
Brigham and Women's Hospital
Cancer Research UK Imperial Centre
CINECA
Duke University
FedDev Ontario
Genome Institute
Harvard Medical School
Institut Carnot CALYM
Merck Global Health Innovation Fund
Multiple Myeloma Research Foundation
U-M Life Sciences Institute
University of California
University of Michigan College of Pharmacy
University of Pittsburgh
Vanderbilt University Medical Center
World Health Organization

$5,056.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838